Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Rausch

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cellular and Molecular Neurobiology|June 1, 1990
Functional expression of dihydropyridine-insensitive calcium channels during PC12 cell differentiation by nerve growth factor (NGF), oncogenic ras, or src tyrosine kinaseD M Rausch, D L Lewis, J L Barker, et al.
Science (New York, N.Y.)|March 6, 1992
Cognitive and motor impairments associated with SIV infection in rhesus monkeysE A Murray, D M Rausch, J Lendvay, et al.
AIDS Research and Human Retroviruses|June 1, 1991
Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1 infection versus HIV-1-induced syncytium formationJ D Lifson, D M Rausch, V S Kalyanaraman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycleP L Nara, K M Hwang, D M Rausch, et al.
The Journal of Infectious Diseases|November 14, 1997
Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDST A Reinhart, M J Rogan, D Huddleston, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 9, 2013
Perspectives from the National Institute of Mental Health: Preventing or living with aidsE S Stover, W L Goldschmidts, L E Grau, et al.
Nature Medicine|February 1, 1997
A new approach to investigating the relationship between productive infection and cytopathicity in vivoT A Reinhart, M J Rogan, G A Viglianti, et al.
Biochemical Pharmacology|April 15, 1992
CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitroD M Rausch, J D Lifson, M P Padgett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.
Journal of Human Virology|July 21, 1999
Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitisQ Li, L E Eiden, W Cavert, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Neurobiology|June 1, 1990
Functional expression of dihydropyridine-insensitive calcium channels during PC12 cell differentiation by nerve growth factor (NGF), oncogenic ras, or src tyrosine kinaseD M Rausch, D L Lewis, J L Barker, et al.
Science (New York, N.Y.)|March 6, 1992
Cognitive and motor impairments associated with SIV infection in rhesus monkeysE A Murray, D M Rausch, J Lendvay, et al.
AIDS Research and Human Retroviruses|June 1, 1991
Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1 infection versus HIV-1-induced syncytium formationJ D Lifson, D M Rausch, V S Kalyanaraman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycleP L Nara, K M Hwang, D M Rausch, et al.
The Journal of Infectious Diseases|November 14, 1997
Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDST A Reinhart, M J Rogan, D Huddleston, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 9, 2013
Perspectives from the National Institute of Mental Health: Preventing or living with aidsE S Stover, W L Goldschmidts, L E Grau, et al.
Nature Medicine|February 1, 1997
A new approach to investigating the relationship between productive infection and cytopathicity in vivoT A Reinhart, M J Rogan, G A Viglianti, et al.
Biochemical Pharmacology|April 15, 1992
CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitroD M Rausch, J D Lifson, M P Padgett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.
Journal of Human Virology|July 21, 1999
Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitisQ Li, L E Eiden, W Cavert, et al.
Pageof 3